Croydon, PA, United States of America

Tomas Santiago Aleman

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Regenxbio Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomas Santiago Aleman. Retrieved from https://idiyas.com/inventor/tomas-santiago-aleman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tomas Santiago Aleman

Introduction

Tomas Santiago Aleman is an accomplished inventor based in Croydon, Pennsylvania. He has made significant contributions to the field of medical treatments, particularly focusing on age-related conditions. His work is characterized by a commitment to improving patient outcomes through innovative solutions.

Latest Patents

Tomas holds a patent for "Compositions for Treatment of Wet Age-Related Macular Degeneration." This patent represents a crucial advancement in the treatment of a condition that affects many individuals as they age. His innovative approach aims to provide effective therapies for those suffering from this debilitating eye disease.

Career Highlights

Tomas is currently employed at Regenxbio Inc., a company known for its pioneering work in gene therapy. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts.

Collaborations

Tomas has worked alongside notable colleagues such as Sherri Van Everen and Jean Bennett. These collaborations have further enriched his research and have led to advancements in the treatment of age-related macular degeneration.

Conclusion

Tomas Santiago Aleman's contributions to the field of medical innovation are noteworthy. His patent for treating wet age-related macular degeneration showcases his dedication to improving healthcare solutions. Through his work at Regenxbio Inc. and collaborations with esteemed colleagues, he continues to make a significant impact in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…